Cargando…

High flow nasal oxygen after bariatric surgery (OXYBAR), prophylactic post-operative high flow nasal oxygen versus conventional oxygen therapy in obese patients undergoing bariatric surgery: study protocol for a randomised controlled pilot trial

BACKGROUND: The incidence of obesity is increasing worldwide. In selected individuals, bariatric surgery may offer a means of achieving long-term weight loss, improved health, and healthcare cost reduction. Physiological changes that occur because of obesity and general anaesthesia predispose to res...

Descripción completa

Detalles Bibliográficos
Autores principales: Fulton, Rachel, Millar, Jonathan E., Merza, Megan, Johnston, Helen, Corley, Amanda, Faulke, Daniel, Rapchuk, Ivan, Tarpey, Joe, Lockie, Philip, Lockie, Shirley, Fraser, John F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6062994/
https://www.ncbi.nlm.nih.gov/pubmed/30053897
http://dx.doi.org/10.1186/s13063-018-2777-2
_version_ 1783342477426556928
author Fulton, Rachel
Millar, Jonathan E.
Merza, Megan
Johnston, Helen
Corley, Amanda
Faulke, Daniel
Rapchuk, Ivan
Tarpey, Joe
Lockie, Philip
Lockie, Shirley
Fraser, John F.
author_facet Fulton, Rachel
Millar, Jonathan E.
Merza, Megan
Johnston, Helen
Corley, Amanda
Faulke, Daniel
Rapchuk, Ivan
Tarpey, Joe
Lockie, Philip
Lockie, Shirley
Fraser, John F.
author_sort Fulton, Rachel
collection PubMed
description BACKGROUND: The incidence of obesity is increasing worldwide. In selected individuals, bariatric surgery may offer a means of achieving long-term weight loss, improved health, and healthcare cost reduction. Physiological changes that occur because of obesity and general anaesthesia predispose to respiratory complications following bariatric surgery. The aim of this study is to determine whether post-operative high flow nasal oxygen therapy (HFNO(2)) improves respiratory function and reduces the incidence of post-operative pulmonary complications (PPCs) in comparison to conventional oxygen therapy in these patients. METHOD: The OXYBAR study is a prospective, un-blinded, single centre, randomised, controlled pilot study. Patients with body mass index (BMI) > 30 kg/m(2), undergoing laparoscopic bariatric surgery, will be randomised to receive either standard low flow oxygen therapy or HFNO(2) in the post-operative period. The primary outcome measure is the change in end expiratory lung impedance (∆EELI) as measured by electrical impedance tomography (EIT). Secondary outcome measures include change in tidal volume (∆Vt), partial arterial pressure of oxygen/fraction of inspired oxygen (PaO(2)/FiO(2)) ratio, incidence of PPCs, hospital length of stay and measures of patient comfort. DISCUSSION: We hypothesise that the post-operative administration of HFNO(2) will increase EELI and therefore end expiratory lung volume (EELV) in obese patients. To our knowledge this is the first trial designed to assess the effects of HFNO(2) on EELV in this population. We anticipate that data collected during this pilot study will inform a larger multicentre trial. TRIAL REGISTRATION: Australian New Zealand Clinical Trials Registry (ANZCTR), ACTRN12617000694314. Registered on 15 May 2017. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s13063-018-2777-2) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-6062994
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-60629942018-07-31 High flow nasal oxygen after bariatric surgery (OXYBAR), prophylactic post-operative high flow nasal oxygen versus conventional oxygen therapy in obese patients undergoing bariatric surgery: study protocol for a randomised controlled pilot trial Fulton, Rachel Millar, Jonathan E. Merza, Megan Johnston, Helen Corley, Amanda Faulke, Daniel Rapchuk, Ivan Tarpey, Joe Lockie, Philip Lockie, Shirley Fraser, John F. Trials Study Protocol BACKGROUND: The incidence of obesity is increasing worldwide. In selected individuals, bariatric surgery may offer a means of achieving long-term weight loss, improved health, and healthcare cost reduction. Physiological changes that occur because of obesity and general anaesthesia predispose to respiratory complications following bariatric surgery. The aim of this study is to determine whether post-operative high flow nasal oxygen therapy (HFNO(2)) improves respiratory function and reduces the incidence of post-operative pulmonary complications (PPCs) in comparison to conventional oxygen therapy in these patients. METHOD: The OXYBAR study is a prospective, un-blinded, single centre, randomised, controlled pilot study. Patients with body mass index (BMI) > 30 kg/m(2), undergoing laparoscopic bariatric surgery, will be randomised to receive either standard low flow oxygen therapy or HFNO(2) in the post-operative period. The primary outcome measure is the change in end expiratory lung impedance (∆EELI) as measured by electrical impedance tomography (EIT). Secondary outcome measures include change in tidal volume (∆Vt), partial arterial pressure of oxygen/fraction of inspired oxygen (PaO(2)/FiO(2)) ratio, incidence of PPCs, hospital length of stay and measures of patient comfort. DISCUSSION: We hypothesise that the post-operative administration of HFNO(2) will increase EELI and therefore end expiratory lung volume (EELV) in obese patients. To our knowledge this is the first trial designed to assess the effects of HFNO(2) on EELV in this population. We anticipate that data collected during this pilot study will inform a larger multicentre trial. TRIAL REGISTRATION: Australian New Zealand Clinical Trials Registry (ANZCTR), ACTRN12617000694314. Registered on 15 May 2017. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s13063-018-2777-2) contains supplementary material, which is available to authorized users. BioMed Central 2018-07-27 /pmc/articles/PMC6062994/ /pubmed/30053897 http://dx.doi.org/10.1186/s13063-018-2777-2 Text en © The Author(s). 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Study Protocol
Fulton, Rachel
Millar, Jonathan E.
Merza, Megan
Johnston, Helen
Corley, Amanda
Faulke, Daniel
Rapchuk, Ivan
Tarpey, Joe
Lockie, Philip
Lockie, Shirley
Fraser, John F.
High flow nasal oxygen after bariatric surgery (OXYBAR), prophylactic post-operative high flow nasal oxygen versus conventional oxygen therapy in obese patients undergoing bariatric surgery: study protocol for a randomised controlled pilot trial
title High flow nasal oxygen after bariatric surgery (OXYBAR), prophylactic post-operative high flow nasal oxygen versus conventional oxygen therapy in obese patients undergoing bariatric surgery: study protocol for a randomised controlled pilot trial
title_full High flow nasal oxygen after bariatric surgery (OXYBAR), prophylactic post-operative high flow nasal oxygen versus conventional oxygen therapy in obese patients undergoing bariatric surgery: study protocol for a randomised controlled pilot trial
title_fullStr High flow nasal oxygen after bariatric surgery (OXYBAR), prophylactic post-operative high flow nasal oxygen versus conventional oxygen therapy in obese patients undergoing bariatric surgery: study protocol for a randomised controlled pilot trial
title_full_unstemmed High flow nasal oxygen after bariatric surgery (OXYBAR), prophylactic post-operative high flow nasal oxygen versus conventional oxygen therapy in obese patients undergoing bariatric surgery: study protocol for a randomised controlled pilot trial
title_short High flow nasal oxygen after bariatric surgery (OXYBAR), prophylactic post-operative high flow nasal oxygen versus conventional oxygen therapy in obese patients undergoing bariatric surgery: study protocol for a randomised controlled pilot trial
title_sort high flow nasal oxygen after bariatric surgery (oxybar), prophylactic post-operative high flow nasal oxygen versus conventional oxygen therapy in obese patients undergoing bariatric surgery: study protocol for a randomised controlled pilot trial
topic Study Protocol
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6062994/
https://www.ncbi.nlm.nih.gov/pubmed/30053897
http://dx.doi.org/10.1186/s13063-018-2777-2
work_keys_str_mv AT fultonrachel highflownasaloxygenafterbariatricsurgeryoxybarprophylacticpostoperativehighflownasaloxygenversusconventionaloxygentherapyinobesepatientsundergoingbariatricsurgerystudyprotocolforarandomisedcontrolledpilottrial
AT millarjonathane highflownasaloxygenafterbariatricsurgeryoxybarprophylacticpostoperativehighflownasaloxygenversusconventionaloxygentherapyinobesepatientsundergoingbariatricsurgerystudyprotocolforarandomisedcontrolledpilottrial
AT merzamegan highflownasaloxygenafterbariatricsurgeryoxybarprophylacticpostoperativehighflownasaloxygenversusconventionaloxygentherapyinobesepatientsundergoingbariatricsurgerystudyprotocolforarandomisedcontrolledpilottrial
AT johnstonhelen highflownasaloxygenafterbariatricsurgeryoxybarprophylacticpostoperativehighflownasaloxygenversusconventionaloxygentherapyinobesepatientsundergoingbariatricsurgerystudyprotocolforarandomisedcontrolledpilottrial
AT corleyamanda highflownasaloxygenafterbariatricsurgeryoxybarprophylacticpostoperativehighflownasaloxygenversusconventionaloxygentherapyinobesepatientsundergoingbariatricsurgerystudyprotocolforarandomisedcontrolledpilottrial
AT faulkedaniel highflownasaloxygenafterbariatricsurgeryoxybarprophylacticpostoperativehighflownasaloxygenversusconventionaloxygentherapyinobesepatientsundergoingbariatricsurgerystudyprotocolforarandomisedcontrolledpilottrial
AT rapchukivan highflownasaloxygenafterbariatricsurgeryoxybarprophylacticpostoperativehighflownasaloxygenversusconventionaloxygentherapyinobesepatientsundergoingbariatricsurgerystudyprotocolforarandomisedcontrolledpilottrial
AT tarpeyjoe highflownasaloxygenafterbariatricsurgeryoxybarprophylacticpostoperativehighflownasaloxygenversusconventionaloxygentherapyinobesepatientsundergoingbariatricsurgerystudyprotocolforarandomisedcontrolledpilottrial
AT lockiephilip highflownasaloxygenafterbariatricsurgeryoxybarprophylacticpostoperativehighflownasaloxygenversusconventionaloxygentherapyinobesepatientsundergoingbariatricsurgerystudyprotocolforarandomisedcontrolledpilottrial
AT lockieshirley highflownasaloxygenafterbariatricsurgeryoxybarprophylacticpostoperativehighflownasaloxygenversusconventionaloxygentherapyinobesepatientsundergoingbariatricsurgerystudyprotocolforarandomisedcontrolledpilottrial
AT fraserjohnf highflownasaloxygenafterbariatricsurgeryoxybarprophylacticpostoperativehighflownasaloxygenversusconventionaloxygentherapyinobesepatientsundergoingbariatricsurgerystudyprotocolforarandomisedcontrolledpilottrial